Overview
Join global regulators, industry, and academia to engage in a series of strategic discussions on current regulatory landscape, globalization, and harmonization initiatives in Latin America.
DIA brings you a symposium with interactive dynamics, where you will be engaged in discussions with key stakeholders influencing the advancement and implementation of regulatory convergence initiatives in Latin America.
Join us to discuss multi-regional cooperation, global harmonization, and best practices related to Latin America’s regulatory landscape. Sessions will highlight regulatory approaches and good practices to ensure reliance in Latin American and strategic initiatives to improve collaboration and cooperation.
LETTER TO SUPPORT YOUR US VISA APPLICATION
DIA can provide a letter to confirm your onsite participation as long as you have:
A) already registered for this conference and
B) paid the registration for this conference.
To request a confirmation letter please send an email to NAEvents@DIAglobal.org
*The primary language is English, however simultaneous interpretation in English and Portuguese will be available during this Conference.
Who should attend?
Professionals involved in:
- Drug Regulation
- Clinical Research and Development
- Medical and Scientific Affairs
- Quality Assurance
- Research and Development
- Strategic Sourcing/Planning
- Regulatory Affairs
Program Committee
-
Patricia Aprea, MD • Director, Evaluation and Control of Biológicals/Research
ANMAT, Argentina -
Cammilla Horta Gomes, MA • LATAM Regulatory Policy Lead
Roche, Brazil -
Maria Guazzaroni Jacobs, PhD • Director, Quality and Regulatory Policy (QRP), Global Supply
Pfizer Inc, United States -
Fernanda Lessa, MBA, MPH • Reg Affairs Specialist, Health Systems/Services and Medicines and Health Tech
Pan American Health Organization (PAHO), United States -
Livia Lopes • LatAm Regulatory Affairs Policy Manager
Novartis, United States -
Roberta Mele Mazza, RPh, RAC • Q&RA Manager, División Diagnóstica
Productos Roche , Argentina -
Maria Cristina Mota Pina, MBA • Director, Regulatory Policy and Intelligence -Japan, Emerging Markets, Australia
AbbVie, Inc., United States -
Carlos Pinoargote • Chief Operating Officer
BRCR, United States -
Ana Padua, MSc, RPh • Associate Director GRA CMC Regulatory Intelligence Biopharam Global Regulatory
EMD Serono, Switzerland -
Leonardo Semprun, RPh • Director, Global Regulatory Policy - Latin America
MSD, Panama -
Renata De Lima Soares • Regulation and Health Surveillance Specialist
Anvisa, Brazil -
Sonia Viejobueno, LLM • Latin America Lead, Global Regulatory Policy and Intelligence
The Janssen Pharmaceutical Companies of Johnson & Johnson, Argentina
Contact us
Registration Questions?
On Demand Content Preview Webinar
Registration Pathways to Accelerate Regulatory Assessment of Innovative Medicines in Latin America
Register Today!
